Zoledronate can promote apoptosis and inhibit the proliferation of colorectal cancer cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Zoledronate can promote apoptosis and inhibit the proliferation of colorectal cancer cells
Authors
Keywords
Zoledronate, Mitochondria apoptosis pathway, Colorectal cancer
Journal
TUMOR BIOLOGY
Volume 36, Issue 7, Pages 5315-5322
Publisher
Springer Nature
Online
2015-02-17
DOI
10.1007/s13277-015-3192-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Zoledronic acid exerts antitumor effects in NB4 acute promyelocytic leukemia cells by inducing apoptosis and S phase arrest
- (2014) Shou-Sheng Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo
- (2014) P. D. Ottewell et al. CLINICAL CANCER RESEARCH
- Survival Benefit of Zoledronic Acid in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
- (2014) Sung Gwe Ahn et al. Journal of Breast Cancer
- Zoledronic acid in the treatment of metastatic breast cancer
- (2013) Ana Lluch et al. ANTI-CANCER DRUGS
- KRAS Mutation Testing in Colorectal Cancer
- (2012) Michel P. Bihl et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- The Ras protein superfamily: Evolutionary tree and role of conserved amino acids
- (2012) Ana Maria Rojas et al. JOURNAL OF CELL BIOLOGY
- The human epidermal growth factor receptor (EGFR) gene in European patients with advanced colorectal cancer harbors infrequent mutations in its tyrosine kinase domain
- (2011) Brigitte Metzger et al. BMC Medical Genetics
- Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy
- (2010) Gur Pines et al. FEBS LETTERS
- Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth
- (2009) Hannu Mönkkönen et al. ANTI-CANCER DRUGS
- Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells
- (2009) Johanna Räikkönen et al. BIOCHEMICAL PHARMACOLOGY
- The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro
- (2009) Laura M. Mitrofan et al. BONE
- Clinical efficacy and safety of zoledronic acid in prostate and breast cancer
- (2009) Sheila A Doggrell Expert Review of Anticancer Therapy
- The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis
- (2008) Lilian Sewing et al. APOPTOSIS
- Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells
- (2008) B KARABULUT et al. CELL BIOLOGY INTERNATIONAL
- Zoledronic Acid and Survival in Patients with Metastatic Bone Disease from Lung Cancer and Elevated Markers of Osteoclast Activity
- (2008) Vera Hirsh et al. Journal of Thoracic Oncology
- Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines
- (2008) Anders Ullén et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started